Concert Pharmaceuticals Reports First Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/16/2026
- Wall Street ends lower as chip weakness offsets solid earnings, economic data
- Netflix earnings forecast disappoints Wall Street, shares tumble
- Alphabet stock falls on report of Gemini AI model delays
- TSMC Q2 profit jumps 77% to record, far surpasses expectations
- Oil settles lower, but remains near one-month high on U.S.-Iran tension
Concert Pharma (CNCE) Misses Q1 EPS by 12c
May 5, 2022 7:29 AM EDTConcert Pharma (NASDAQ: CNCE) reported Q1 EPS of ($1.03), $0.12 worse than the analyst estimate of ($0.91).
For earnings history and earnings-related data on Concert Pharma (CNCE) click here.
... More